InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (18 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
18
T+90 hit rate
50%
T+90 mean return
-1.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Chacko Jacob, Chairman & CEO. Director active across 3 companies, notably Oric Pharmaceuticals, Inc.. In total, 26 disclosures have been published. Split: 2 buys · 18 sells. Total volume traded: €5.7m. History available since 11 May 2021. The latest transaction was disclosed on 15 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Chacko Jacob
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
83,666 shares0Common StockSEC:0001608936-25-000014:0
37,461 shares@ US$12.327.0% of flowCommon StockSEC:0001608936-25-000010:0
34,538 shares@ US$12.00856.8% of flowCommon StockSEC:0001608936-25-000008:0
125,000 shares@ US$10.799523.5% of flowCommon StockSEC:0001608936-25-000006:0
67,000 shares0Common StockSEC:0001415889-24-029631:0
40,000 shares@ US$16.209513.6% of flowCommon StockSEC:0001415889-24-007345:0
13,958 shares@ US$12.11923.6% of flowCommon StockSEC:0001415889-24-003114:0
38,667 shares0Common StockSEC:0001209191-23-059263:0
10,508 shares@ US$8.01411.7% of flowCommon StockSEC:0001209191-23-042054:0
5,156 shares@ US$8.00760.9% of flowCommon StockSEC:0001209191-23-042054:1
4,336 shares@ US$8.00520.7% of flowCommon StockSEC:0001209191-23-041805:0
20,000 shares@ US$8.02813.4% of flowCommon StockSEC:0001209191-23-040090:0
5,000 shares@ US$9.4131.9% of flowCommon StockSEC:0001140361-23-020315:0
5,000 shares@ US$20.053968.1% of flowCommon StockSEC:0001140361-23-020315:1
6,137 shares@ US$3.0730.4% of flowCommon StockSEC:0001209191-23-010607:0
16,666 shares0Common StockSEC:0001209191-22-061754:0
304,574 shares@ US$2.9010.100% mcap25.4% of flowCommon StockSEC:0001209191-22-028963:0
Canonical exit: 9 Aug 2022 (T+90)
257,127 shares@ US$4.98150.14% mcap35.0% of flowCommon StockSEC:0001209191-22-021153:0
Canonical exit: 21 Jun 2022 (T+90)
4,420 shares@ US$25.04671.7% of flowCommon StockSEC:0001209191-21-056460:0
2,942 shares@ US$25.07931.1% of flowCommon StockSEC:0001209191-21-055866:0
5,981 shares@ US$25.10842.3% of flowCommon StockSEC:0001209191-21-055291:0
400 shares@ US$25.070.1% of flowCommon StockSEC:0001209191-21-036686:0
2,468 shares@ US$25.06640.9% of flowCommon StockSEC:0001209191-21-035523:0
13,896 shares@ US$25.36455.2% of flowCommon StockSEC:0001209191-21-033813:0
1,090 shares@ US$25.21980.4% of flowCommon StockSEC:0001209191-21-032508:0
25 of 26 declarations
About Chacko Jacob
Chacko Jacob is President and CEO and has made 26 filings in total. Across the 26 sampled filings, the transactions span 2016-01-11 to 2025-12-17, with EUR 2001791 of buys and EUR 3704629 of sells, and the most common transaction nature is Sale. The filings cited concern Oric Pharmaceuticals, Inc.
